Fetal trisomy 13 risk:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA

Preferred Label : Fetal trisomy 13 risk:Imp:Pt:Plas.cfDNA:Ord:Dosage of chromosome specific cf DNA;

LOINC status : ACTIVE;

LOINC display name : Trisomy 13 risk Dosage of chromosome-specific cfDNA Ql (cfDNA) [Interp];

LOINC long common name : Fetal Trisomy 13 risk [Interpretation] based on Plasma cell-free DNA by Dosage of chromosome-specific cfDNA Qualitative;

LOINC short name : Fet Ts 13 risk Plas.cfDNA Ql;

LOINC description : Trisomy 13 (T13) ordinal risk (high/low) can be determined based on dosage of chromosome specific circulating cell free (ccf) DNA in maternal plasma, the mother's current age and gestational age. The ccf DNA includes both fetal and maternal DNA. This code is based, but not limited in use to, the submitter's test, Harmony Prenatal Test, which is a non-invasive prenatal test intended to aid in the risk determination of fetal trisomy 13, 18 and 21 in women with singleton pregnancies of at least 10 weeks gestational age.;

Details

Origin ID

73824-5;

UMLS CUI

C3654205;

Has component
- Fetal trisomy 13 risk [LOINC component]
Has method
- Dosage of chromosome-specific cfDNA [LOINC method]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Ord [LOINC scale]
Has system
- Plasma [LOINC System]
- Plasma cell-free DNA [LOINC System]
- cell free DNA [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Noninvasive prenatal fetal aneuploidy panel:-:Pt:Plas.cfDNA:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients